Portfolio Holdings Detail for ISIN IE00BD93YH54
Stock Name / FundiShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF TickerSPMD(USD) LSE
ETF TickerSPMD.LS(USD) CXE
ETF TickerSPMD.L(GBP) LSE

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2026-02-09 (Monday)7,774USD 6,065,897USD 6,065,897
2026-02-06 (Friday)7,774REGN holding increased by 77USD 6,106,555REGN holding increased by 295166USD 6,106,55577USD 295,166 USD 785.51 USD 755.02
2026-02-02 (Monday)7,697USD 5,811,389REGN holding increased by 104448USD 5,811,3890USD 104,448 USD 755.02 USD 741.45
2026-01-30 (Friday)7,697USD 5,706,941REGN holding decreased by -61499USD 5,706,9410USD -61,499 USD 741.45 USD 749.44
2026-01-29 (Thursday)7,697REGN holding increased by 11USD 5,768,440REGN holding decreased by -4745USD 5,768,44011USD -4,745 USD 749.44 USD 751.13
2026-01-28 (Wednesday)7,686USD 5,773,185REGN holding decreased by -154643USD 5,773,1850USD -154,643 USD 751.13 USD 771.25
2026-01-27 (Tuesday)7,686USD 5,927,828REGN holding increased by 66100USD 5,927,8280USD 66,100 USD 771.25 USD 762.65
2026-01-26 (Monday)7,686USD 5,861,728REGN holding increased by 69943USD 5,861,7280USD 69,943 USD 762.65 USD 753.55
2026-01-23 (Friday)7,686REGN holding decreased by -33USD 5,791,785REGN holding decreased by -39997USD 5,791,785-33USD -39,997 USD 753.55 USD 755.51
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00BD93YH54

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06BUY77 785.510* -
2026-01-29BUY11755.730742.885 744.170USD 8,186 -
2026-01-23SELL-33762.000747.300 748.770USD -24,709 -
2026-01-21SELL-44749.550735.000 736.455USD -32,404 -
2026-01-16SELL-22749.090726.950 729.164USD -16,042 -
2026-01-14BUY33766.640753.010 754.373USD 24,894 -
2026-01-13BUY77765.990743.940 746.145USD 57,453 -
2026-01-05BUY22771.990753.199 755.078USD 16,612 -
2025-12-29BUY169784.990774.595 775.634USD 131,082 -
2025-12-24BUY11792.770783.610 784.526USD 8,630 -
2025-12-24BUY11792.770783.610 784.526USD 8,630 -
2025-12-23BUY374792.750777.000 778.575USD 291,187 -
2025-12-22SELL-11783.600765.090 766.941USD -8,436 -
2025-12-19SELL-165773.850748.180 750.747USD -123,873 -
2025-12-17SELL-55751.990743.330 744.196USD -40,931 -
2025-12-16SELL-539757.350734.720 736.983USD -397,234 -
2025-12-15SELL-319756.660746.375 747.403USD -238,422 -
2025-12-09BUY11711.000691.890 693.801USD 7,632 -
2025-12-04BUY22735.000721.220 722.598USD 15,897 -
2025-11-26BUY209790.980777.000 778.398USD 162,685 -
2025-11-26BUY209790.980777.000 778.398USD 162,685 -
2025-11-25BUY44790.570760.700 763.687USD 33,602 -
2025-11-24BUY33773.130756.640 758.289USD 25,024 -
2025-11-21BUY22764.090735.740 738.575USD 16,249 -
2025-11-20BUY44753.510720.020 723.369USD 31,828 -
2025-11-11BUY154676.330651.410 653.902USD 100,701 -
2025-11-10SELL-154665.990653.190 654.470USD -100,788 -
2025-11-07SELL-132658.210640.990 642.712USD -84,838 -
2025-11-06BUY132657.000641.260 642.834USD 84,854 -
2025-11-04SELL-11646.221625.140 627.248USD -6,900 -
2025-10-27BUY44585.310586.150 586.066USD 25,787 -
2025-10-22SELL-22584.740588.710 588.313USD -12,943 -
2025-10-20BUY66576.770582.650 582.062USD 38,416 -
2025-10-15SELL-44576.420584.870 584.025USD -25,697 -
2025-10-14BUY22572.600576.180 575.822USD 12,668 -
2025-10-03BUY22600.000618.010 616.209USD 13,557 -
2025-09-30BUY11562.270574.040 572.863USD 6,301 -
2025-09-25BUY11555.510579.000 576.651USD 6,343 -
2025-07-16SELL-390547.930558.350 557.308USD -217,350 -
2025-07-14SELL-52570.590575.130 574.676USD -29,883 -
2025-07-11SELL-78567.740568.460 568.388USD -44,334 -
2025-07-10SELL-26559.760566.370 565.709USD -14,708 -
2025-07-09SELL-52552.580558.380 557.800USD -29,006 -
2025-07-03SELL-390547.360555.000 554.236USD -216,152 -
2025-07-02SELL-50547.740551.500 551.124USD -27,556 -
2025-06-27SELL-52521.000531.210 530.189USD -27,570 -
2025-06-23SELL-52511.920516.180 515.754USD -26,819 -
2025-06-20SELL-26509.720521.310 520.151USD -13,524 -
2025-06-18SELL-50513.580519.170 518.611USD -25,931 -
2025-06-16SELL-312522.680538.200 536.648USD -167,434 -
2025-06-13SELL-1,278529.240529.550 529.519USD -676,725 -
2025-06-12SELL-1,151521.840525.220 524.882USD -604,139 -
2025-06-11SELL-52518.600528.370 527.393USD -27,424 -
2025-06-06BUY78493.220499.880 499.214USD 38,939 -
2025-06-05BUY104483.070491.770 490.900USD 51,054 -
2025-05-28SELL-78591.850606.000 604.585USD -47,158 -
2025-05-27BUY78603.260608.170 607.679USD 47,399 -
2025-05-23SELL-234588.340591.640 591.310USD -138,367 -
2025-05-22BUY52596.850605.500 604.635USD 31,441 -
2025-05-20BUY234614.790615.450 615.384USD 144,000 -
2025-05-16BUY99594.320595.190 595.103USD 58,915 -
2025-05-15BUY100584.990585.260 585.233USD 58,523 -
2025-05-14SELL-675571.360580.560 579.640USD -391,257 -
2025-05-13BUY50574.160575.050 574.961USD 28,748 -
2025-05-12BUY125575.630577.990 577.754USD 72,219 -
2025-05-09SELL-100527.780552.840 550.334USD -55,033 -
2025-05-08BUY75547.670552.570 552.080USD 41,406 -
2025-05-07SELL-125560.930568.130 567.410USD -70,926 -
2025-04-30SELL-25598.760600.200 600.056USD -15,001 -
2025-04-28SELL-150610.860614.830 614.433USD -92,165 -
2025-04-23BUY25587.850603.770 602.178USD 15,054 -
2025-04-15BUY325557.910575.200 573.471USD 186,378 -
2025-04-14BUY50571.060574.720 574.354USD 28,718 -
2025-04-09SELL-150576.720580.730 580.329USD -87,049 -
2025-04-08BUY75556.810586.030 583.108USD 43,733 -
2025-04-04BUY150573.450612.990 609.036USD 91,355 -
2025-04-02BUY73625.600628.000 627.760USD 45,826 -
2025-04-01SELL-225617.000641.240 638.816USD -143,734 -
2025-03-31BUY1,184634.230640.720 640.071USD 757,844 -
2025-03-28BUY150637.360642.970 642.409USD 96,361 -
2025-03-27BUY294635.830643.430 642.670USD 188,945 -
2025-03-26BUY748640.140644.000 643.614USD 481,423 -
2025-03-25BUY513634.140662.570 659.727USD 338,440 -
2025-03-24SELL-75661.000667.460 666.814USD -50,011 -
2025-03-21SELL-4,100658.480661.000 660.748USD -2,709,067 -
2025-03-19BUY91672.360674.570 674.349USD 61,366 -
2025-03-17SELL-188678.420679.830 679.689USD -127,782 -
2025-03-14SELL-94666.870686.980 684.969USD -64,387 -
2025-03-13SELL-94680.610698.950 697.116USD -65,529 -
2025-03-12SELL-188689.500712.460 710.164USD -133,511 -
2025-03-07BUY282707.510729.750 727.526USD 205,162 -
2025-02-28BUY282698.740708.580 707.596USD 199,542 -
2025-02-26BUY376706.940721.410 719.963USD 270,706 -
2025-02-21BUY564700.330704.080 703.705USD 396,890 -
2025-02-18BUY188680.000689.950 688.955USD 129,524 -
2025-02-11BUY470665.460680.790 679.257USD 319,251 -
2025-02-07BUY188710.000731.420 729.278USD 137,104 -
2025-02-06BUY94722.070734.270 733.050USD 68,907 -
2025-02-05BUY282716.720729.250 727.997USD 205,295 -
2025-02-04BUY94697.050709.980 708.687USD 66,617 -
2025-01-31SELL-188672.980688.000 686.498USD -129,062 -
2025-01-29SELL-188687.270697.570 696.540USD -130,950 -
2025-01-02SELL-557715.190726.810 725.648USD -404,186 -
2024-12-10SELL-94778.500791.490 790.191USD -74,278 -
2024-12-09SELL-94788.000800.990 799.691USD -75,171 -
2024-11-27SELL-188754.870762.160 761.431USD -143,149 -
2024-11-21SELL-376744.500757.560 756.254USD -284,352 -
2024-11-20SELL-188743.350750.690 749.956USD -140,992 -
2024-11-18SELL-188762.000762.700 762.630USD -143,374 -
2024-11-12SELL-564821.000831.000 830.000USD -468,120 -
2024-11-08SELL-1,504828.420830.730 830.499USD -1,249,070 -
2024-11-07SELL-658824.480832.530 831.725USD -547,275 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy